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Highlights 
 
• There is a range of therapies used in the management of vascular anomalies 
depending upon the character of the lesion. 
• Photodynamic therapy is an evolving technology, used in the treatment of 
advanced tumours and vascular anomalies. 
• This case report proves PDT to be an appropriate treatment option for this 
gigantic haemangioma in an 11-year-old PHACE syndrome patient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vascular anomalies are congenital vascular tissue aberrations, which are commonly 
identified in the head and neck and known to affect approximately 1 in 22 children. 
The most recent classification of vascular anomalies includes two main categories: 
vascular tumours (haemangiomas) and vascular malformations
1
.  
 
Several problems can arise from vascular tumours, including functional (through 
mass effect), aesthetic impairment, pain, bleeding (platelet sequestration) and 
disability
2
. They are known to be associated with a number of syndromes involving 
the head and neck, including PHACE (posterior fossa malformations – haemangiomas 
– arterial anomalies – cardiac defects – eye abnormalities)
3
.  
 
PHACE syndrome is a rare association between cervicofacial haemangiomas, 
structural brain abnormalities (mainly of the posterior fossa), arterial and 
cerebrovascular anomalies, aortic and cardiac abnormalities as well as eye defects. It 
represents a fairly common syndrome, identified in 1996 and more common in 
females. The haemangioma component in PHACE is very small or not even visible at 
birth but it is known to grow very fast over the face and head and neck region. The 
genetic component is still undergoing investigations and no familial cases have been 
identified. Multi-disciplinary team is required for managing this unique group of 
patients
3
. 
 
Conventional management of cervicofacial haemangiomas can include systemic or 
intra-lesional corticosteroids, beta-blockers, chemotherapeutic agents, surgery, laser 
or a combination of these therapies. Where lesions are large, surgery can have 
marked adverse effect on form and function and due to difficulty in delineating 
these lesions, recurrence can be high. The side effects of chemotherapy are well 
known and radiotherapy carries the risk of inducing new tumours
1,5
. 
 
Photodynamic therapy with interstitial illumination (iPDT) is a technique developed 
for the treatment of deep-seated malformations and falls within the minimal surgical 
approach. Previously PDT for vascular anomalies has been used primarily for the 
management of age-related macular degeneration. It has been described as effective 
in the treatment of port-wine stain birthmarks, alone and in combination with 
pulsed dye laser therapy. There are relatively few studies in the literature describing 
the use of PDT for deep-seated vascular anomalies
4
.  
 
We report the use of Ultrasound guided iPDT (US-iPDT) in the management of a 
gigantic haemangioma of an 11-year-old PHACE syndrome Asian male with an on-
going breathing, swallowing and speaking problems as well as severe facial 
deformity.  
 
An 11-year-old Asian male was referred to the University College London Hospital 
Head and Neck Centre, London for management of a gigantic haemangioma 
involving various parts of his head and neck as part of PHACE syndrome. The child 
syndromic features included posterior fossa abnormalities, extensive haemangioma 
of the nasopharynx, oropharynx and supraglottis with extensions to many tissues 
and structures in the cervicofacial region, arterial cerebrovascular anomalies, cardiac 
defect (aortic coarctation) and eye anomalies. 
 
The patient has received a number of conventional interventions over the years to 
manage the problems arising from the extensive size of the lesion, including 
breathing, swallowing and speaking problems. At time of presentation, he had 
difficulty controlling the food and saliva in the mouth and it was difficult to initiate 
swallowing and coughing. He was unable to swallow solid food, and had difficulty 
managing fluids and semi-solid food. His breathing was laboured and difficult at rest 
most of the time; and there was difficulty in speaking with gurgling sound. The 
patient suffered regularly from lower respiratory tract infections and sometimes 
required to be on antimicrobials for several months. Local bleeding and infections of 
the haemangioma caused continuous problems and required multiple hospital 
admissions in the past. At the time of referral the patient had exhausted all 
conventional interventions that were applicable to his age and no other options 
were being considered.  
 
Physical examination of the lesion was a challenge. The haemangioma involved the 
cervicofacial tissues, especially the mid and lower face, upper one third of the neck, 
oral cavity, nasopharynx and oropharynx. Severe oedema, ecchymosis petechiae and 
purpura were noted over the facial skin. Posterior fossa abnormalities, arterial 
cerebrovascular anomalies and eye anomalies were assessed by a number of 
investigations and found to be stable. Cardiac defects were assessed by an 
echocardiogram and were found to be stable. Due to the worsening breathing 
pattern, an urgent surgical tracheostomy had to be undertaken to maintain the 
airway. Flexible ﬁberoptic laryngoscopy revealed lesional extension to the tongue 
base and supraglottis. Fine needle aspiration cytology (FNAC) was performed and 
malignant change was ruled out. The FNAC report highlighted the presence of 
haemangioma with fatty metaplasia. 
 
A pre-intervention MRI revealed a soft tissue mass extending from the face down to 
the larynx. A large number of feeding vessels were identified, deeming the lesion 
unsuitable for embolization or surgical excision. Bilateral jugular stents were noted 
extending almost to the skull base. There were a number of phleboliths (small local 
calcifications within a vein) noted throughout the mass suggestive of a venous 
component. The pathological process extended into the superior mediastinum. 
There was almost complete circumferential involvement of the subglottis causing 
50% narrowing of the airway. Due to its large size, surgical resection carried a 
significant risk to the vessels and neurological structures close to the lesion. 
 
Following discussion at a multi-disciplinary team meeting, it was decided that the 
most suitable option was to treat the lesion with ultrasound-guided interstitial 
photodynamic therapy (US-iPDT) under general anaesthesia. The patient’s family 
signed an informed consent for the procedure to be carried out. Meta-tetra-
hydroxyphenyl chlorine (mTHPC) was administered at a dose of (0.15mg/kg) 
intravenously into the mid-cubital vein 96 hours prior to pathology illumination.  
 
18 Gauge 70mm long spinal needles were inserted under US guidance into the right 
and left cervicofacial portions of the haemangioma. Other needles were inserted to 
manage other components including the oral tongue and tongue base. The area of 
treatment was scanned by ultrasound (EMP 1100 with high resolution) prior to 
needle insertion, to ensure accurate identification of the target volume (Figure 1). 
Diffuser fibres were used instead of bare polished tip fibres. The structure of the 
vascular tumour allows maximal tissue illumination when using diffuser fibres. The 
fibres with core diameter of 400µm were introduced into the spinal needles. A four-
channel 652nm diode laser was used for illumination and 20J/cm
2
 was delivered per 
station to the target tissue (Figure 2).  
 
No immediate complications were reported after this intervention. On day 5 post-
PDT, the tracheostomy tube was removed without any problems. During the first 4 
weeks post-illumination, a gradual improvement of breathing, swallowing and 
speaking symptoms were noted. Gradual re-exposure to light was carried out at an 
incremental rate of 100 lux per day. The patient was advised about the need to avoid 
direct exposure to sunlight for up to 2 weeks after the photosensitiser 
administration and this was explained to the parents and they were provided with 
light exposure guidelines.   
 
The clinical assessment revealed an excellent response of the haemangioma after 
only one round of photodynamic therapy. At the last clinical review, the dysphagia 
has significantly improved along with the breathing problems, which has become 
less labored, and only difficult after exercise and no gurgling sound. The patient 
reported a better control of fluid and saliva in the mouth. The patient started to 
manage small chunks of solid food and it became easier with fluids and semi-solid 
food. A 6-week post-PDT MRI showed signiﬁcant reduction in the size of the 
haemangioma by about 70% (Figure 3). The patient’s pathology continues to be in a 
stable state 4 years after the intervention. The rate of local bleeding and infections, 
along with lower respiratory tract infections became less after one treatment round 
of US-iPDT. 
 
The management of vascular anomalies continues to be extremely challenging. 
Although several modalities have been developed and the literature reports 
successful treatment in many, data from long-term studies reports relapse in many 
and the need for re-treatment or another intervention. US-iPDT is not superior to 
other modalities, but it is characterised by being one of the least invasive, being 
repeatable with no residual toxicity and with minimal bystander effect
1,4,5,6
. This case 
report proves US-iPDT to be an appropriate treatment option for this complex 
vascular anomaly.  
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Figure captions 
 
Figure 1: US-iPDT: Patient draped, prepped and eye shield applied; Left: examination 
under anaesthesia (EUA).  Top right: ultrasonic examination of the haemangima. 
Bottom right: needle insertion under ultrasound guidance. 
 
Figure 2:  US-iPDT: Left: light delivery to the oral tongue. Top right: Light delivery to 
the right facial part of the haemangioma. Bottom right: light delivery to the left facial 
part of the haemangioma. 
 
Figure 3: Left: pre-PDT scan showing the extensive haemangioma. Top right and 
bottom right: 6 weeks post-PDT scan showing significant shrinkage of the lesion. 
 



